Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026
Rhea-AI Summary
Modular Medical (NASDAQ:MODD) announced a free webinar titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch" featuring CEO Jeb Besser on May 1, 2026 at 8:00 AM PT / 11:00 AM ET.
The event will include a presentation and live Q&A hosted by Tribe Public; registration is available at MODD-May-Watch.TribePublic.com.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – MODD
On the day this news was published, MODD declined 3.25%, reflecting a moderate negative market reaction. This price movement removed approximately $809K from the company's valuation, bringing the market cap to $24.08M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Pre-news, MODD was down 0.92% while close peers showed mixed moves (e.g., ECOR +1.65%, IINN -4.02%, MYO +2.03%, RBOT -3.49%). No coordinated sector direction or momentum flags appeared.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 19 | Equity offering | Negative | -7.7% | Registered direct offering of 750,000 shares at $4.50 for ~$3.4M. |
| Apr 16 | Listing compliance | Positive | +3.0% | Regained Nasdaq minimum bid price compliance after 10 days above $1.00. |
| Apr 09 | Regulatory clearance | Positive | -1.6% | Received FDA 510(k) clearance for Pivot tubeless insulin patch pump. |
| Mar 26 | Reverse stock split | Negative | -9.8% | 1-for-30 reverse split to increase price and meet Nasdaq bid requirement. |
| Mar 03 | Public offering | Negative | +7.0% | Public offering of 68,098,000 shares/warrants to raise ~$12.0M. |
Recent history shows negative reactions to dilution and a reverse split, while regulatory or listing-compliance positives have produced mixed to modestly positive moves.
Over the last two months, Modular Medical has executed multiple financings, a 1-for-30 reverse split, and secured FDA 510(k) clearance for its Pivot insulin patch pump, along with regaining Nasdaq minimum bid compliance. Offerings in March and April 2026 led to both positive and negative price reactions, while the FDA clearance on April 9, 2026 saw a small decline. Against this backdrop, the current webinar announcement highlights ongoing investor-relations efforts around commercialization and manufacturing.
Regulatory & Risk Context
An effective Form S-3 shelf dated 2026-04-23 allows Modular Medical to offer up to $150,000,000 of various securities, alongside an at-the-market sales agreement for up to $100,000,000 of common stock. As of this context, reported shelf usage count is 0, and the shelf is marked as not yet effective in the provided data.
Market Pulse Summary
This announcement highlights an investor webinar featuring the CEO discussing FDA clearance and manufacturing scale-up for the Pivot insulin patch pump. It follows recent milestones including FDA 510(k) clearance, Nasdaq bid-price compliance, several equity financings, and a new $150,000,000 shelf registration. Investors may monitor how management frames commercialization timelines, manufacturing readiness, and capital needs, alongside prior actions such as the 1-for-30 reverse split and recent registered direct offerings.
Key Terms
insulin pump medical
patch pump medical
fda-cleared regulatory
bolus medical
AI-generated analysis. Not financial advice.
Meet with Modular Medical CEO Jeb Besser
There are 4.8 million individuals with diabetes in the US that require daily insulin. Only
20% currently use an insulin pump.
Discover Modular Medical's Pivot, the first FDA-cleared, two-part tubeless patch pump featuring a removable 3 mL reservoir, disposable battery, smartphone connectivity for bolus and monitoring, and true electronic accuracy without tubes or constant wear and its associated commercial & manufacturing timeline.
Register at MODD-May-Watch.TribePublic.com
SAN DIEGO, CA / ACCESS Newswire / April 29, 2026 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a leader in innovative, patient-centric insulin delivery, today announced that Jeb Besser, CEO of Modular Medical, will present at Tribe Public's Webinar Presentation and Q&A Event titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." The event is scheduled to begin at 8 a.m. pacific / 11 a.m. eastern on Friday, May 1, 2026. To register to join the complimentary event, please visit the Tribe Public LLC at MODD-May-Watch.TribePublic.com.
Once registered, participants may begin forwarding their questions for the CEO to Tribe Public at research@tribepublic.com or share their questions via the ZOOM chat feature during the event. Tribe Public's Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management.
About Modular Medical
Modular Medical, Inc. (NASDAQ:MODD) is a medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes, taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump
More information is available at https://modular-medical.com.
Pivot is a trademark of Modular Medical in the United States. All trademarks mentioned herein are the property of their respective owners.
ABOUT TRIBE PUBLIC LLC
Tribe Public LLC, headquartered in San Francisco, California, is a distinguished organization that facilitates corporate sponsored global webinars and in-person meetings events across 41 premier venues throughout the United States. Tribe Public's events are tailored to address topics of significant interest to its members, with a particular emphasis on providing direct access to management teams and leading experts from diverse sectors who seek to enhance awareness of their products, achievements, and strategic initiatives. The Tribe's membership is composed primarily of Family Offices, Portfolio Managers, Registered Investment Advisors, Accredited Investors, Sell Side Analysts, and media professionals, all of whom benefit from exclusive opportunities for business development, community building, and informed dialogue in a collegial setting. Members are actively encouraged to shape the event agenda by submitting speaker and company preferences through Tribe Public's complimentary "Wish List" process on its website, ensuring that the programming reflects the evolving interests of its sophisticated community. To learn more about Tribe Public's offerings and to participate in upcoming events, visit their website at: http://www.tribepublic.com/
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire